Subtype-specific transcription factors are clinically relevant and show distinct therapeutic vulnerabilities in human small cell lung cancer
C Lang, Z Megyesfalvi,B Szeitz, A Lantos, N Woldmar, Z Valko, A Schwendenwein, F Oberndorfer,N Barany, S Paku, V Laszlo, H Kiss, E Bugyik,B Ferencz, K Dezso,Z Lohinai, J Moldvay, J Fillinger, G Galffy,C Rivard,F R Hirsch,L Brcic,H Popper, I Kern, M Kovacevic, J Skarda, M Mittak,A M Szasz,L Pizzatti, K Bogos, M A Hoda, K Hoetzenecker, G Marko-Varga, P Horvatovics, F Renyi-Vamos, T Klikovits, K Schelch, M Rezeli, B Döme 11.01 - Lung cancer（2022）
关键词
Lung cancer, Personalised medicine, Experimental approaches
AI 理解论文
溯源树
样例
